Bykerk, Vivian P.
Article History
First Online: 1 April 2018
Competing interests
: V.P.B. declares she has acted as an adviser for Amgen, BMS, Pfizer, Sanofi-Genzyme and UCB, and that her institute has received research funding from Amgen, BMS and UCB.